Apilan, Faustino .

HRN: 27-60-54  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/08/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/08/2025
08/15/2025
IV
1.5gm
Q6
Cellulitis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: